Raymond James & Associates First Tr ETF Vi Nasdaq Pharmac Transaction History

Raymond James & Associates

  • $150 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023
SELL
$25.25 - $28.3 $81,734 - $91,607
-3,237 Reduced 22.21%
11,336 $295,000
Q4 2022

Feb 08, 2023
SELL
$26.13 - $28.45 $2.89 Million - $3.14 Million
-110,452 Reduced 88.34%
14,573 $399,000
Q3 2022

Oct 25, 2022
BUY
$24.2 - $27.17 $3.03 Million - $3.4 Million
125,025 New
125,025 $3.01 Million

Others Institutions Holding FTXH

# of Institutions
22
Shares Held
271K
Call Options Held
0
Put Options Held
0
View Full List

About FIRST TR ETF VI NASDAQ PHARMAC

FTXH Quotes by TradingView
  • Ticker FTXH
  • Sector ETFs
  • Industry ETFs
More about FTXH
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email